2011 Buick Enclave CXL-1
3.6 L • V6 • FWD • AT
5GAKRBED4BJ220021
Sales history: 1
• $400Highlights
Condition
Not provided
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.6 L • V6 • FWD • AT
Odometer
208,651 mi ≈ 335,790 km
Primary damage
Rear end
Secondary damage
Front end
Docs
MI • Cert Title
Extra
Auction
VIN
5GAKRBED4BJ220021
Lot number
84904165
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Wayland, MI
Description
Fuel type
Gasoline
Body color
Charcoal
Body type
SUV
Generation
Lambda
Trim
CXL-1
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2011 Buick Enclave CXL-1 • 3.6 L • V6 • FWD • Automatic • Copart Lot: 84904165 • VIN: 5GAKRBED4BJ220021
Find out more about this 2011 Buick Enclave CXL-1, available at the Copart salvage car auction as lot 84904165 in Wayland, MI. This car has Rear end main damage. It is listed with start condition code. Odometer shows 208,651 mi. This Charcoal Buick Enclave SUV is equipped with Gasoline 3.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 5GAKRBED4BJ220021 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
